Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Impact of Septal Vs Apical Pacing on Right and Left Ventricular Performance

This study is currently recruiting participants. (see Contacts and Locations)
Verified November 2013 by St. Jude Medical
Sponsor:
Information provided by (Responsible Party):
St. Jude Medical
ClinicalTrials.gov Identifier:
NCT01798043
First received: February 21, 2013
Last updated: November 14, 2013
Last verified: November 2013

February 21, 2013
November 14, 2013
January 2013
June 2015   (final data collection date for primary outcome measure)
Change in LV chamber volumes. [ Time Frame: 12 months (baseline to end of study) ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT01798043 on ClinicalTrials.gov Archive Site
  • Change in Dyssynchrony [ Time Frame: 12 months ] [ Designated as safety issue: No ]
  • Change in Ejection fraction [ Time Frame: 12 months ] [ Designated as safety issue: No ]
  • Change in Strain rate [ Time Frame: 12 months ] [ Designated as safety issue: No ]
Same as current
Not Provided
Not Provided
 
Impact of Septal Vs Apical Pacing on Right and Left Ventricular Performance
Impact of Septal Vs Apical Pacing on Right and Left Ventricular Performance

The study aims to use cardiac MRI scans and analysis techniques to evaluate differences in cardiac function after 12 months of pacing in patients with pacing leads placed in different positions within the right ventricle (apically or septally).

Not Provided
Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample

Patients previously implanted with a pacemaker system not contraindicated for use in an MRI scanner.

  • Heart Block
  • Sick Sinus Syndrome
  • Atrioventricular Block
  • Ventricular Dysfunction
Not Provided
  • Septal RV lead with >50% pacing
  • Septal RV lead with <50% pacing
  • Apical RV lead with >50% pacing
  • Apical RV lead with <50% pacing
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
50
June 2015
June 2015   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Have been implanted with an Accent MRI pacemaker and Tendril MRI leads.
  • Have an RV lead implanted apically (group A) or septally (Group B)
  • Are RV paced for <50% of the time (groups A2 and B2)
  • Are RV paced for > 50% of the time (Groups A1 and B1)
  • Are ≥ 18 years of age.
  • Are able to provide written informed consent.
  • Are willing and able to comply with the prescribed follow-up tests and schedule of evaluations.

Exclusion Criteria:

  • Have permanent atrial fibrillation with preserved intrinsic conduction
  • Have a non-MRI compatible device or material implant (e.g., intracranial aneurysm clip, non-MRI compatible devices or material, metals or alloys, etc.).
  • Have a lead extender, plug or adaptor.
  • Do not have an RV lead implanted apically or septally.
  • Are eligible for groups A1 or B1 but appropriate group already has 20 patients enrolled.
  • Are eligible for groups A2 or B2 but appropriate group already has 5 patients enrolled
  • Are currently participating in another device or drug investigation which includes an active treatment arm.
  • Are pregnant or planning to become pregnant during the duration of the study.
  • Have a life expectancy of less than 12 months from Screening due to any life-threatening condition.
  • Are contraindicated for an MRI scan due to any other reason.
Both
18 Years and older
No
Contact: Marcus Simon +32 277 46758 msimon@sjm.com
Switzerland
 
NCT01798043
CR-12-048-CH-LV
No
St. Jude Medical
St. Jude Medical
Not Provided
Principal Investigator: Rainer Zbinden, MD Triemli Hospital
St. Jude Medical
November 2013

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP